Evaluation of Serum Lipid Concentrations among U.S. Workers Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
- 1 April 1996
- journal article
- research article
- Published by Taylor & Francis in Archives of environmental health
- Vol. 51 (2), 100-107
- https://doi.org/10.1080/00039896.1996.9936001
Abstract
2,3,7,8-Tetrachlorodibenzo-p-dioxin alters lipid metabolism in animals; however, evidence for such an effect in humans is conflicting. This conflict was addressed using data from a cross-sectional medical study conducted between 1987 and 1988. The exposed participants had been employed at least 15 y earlier in the manufacture of 2,4, 5-trichlorophenol or one of its derivatives at two chemical plants in the United States. A total of 281 workers and 260 unexposed referents participated. Workers had substantial exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, evidenced by a median serum 2,3,7,8-tetrachlorodibenzo-p-dioxin concentration of 406.6 femtograms/gram of serum (fg/g serum), compared with 36.9 fg/g serum among the referents. A slight association between triglyceride concentration and serum 2,3,7,8-tetrachlorodibenzo-p-dioxin concentration was found (p = .05). Over the range of observed 2,3,7,8-tetrachlorodibenzo-p-dioxin values (i.e., 37–19 000 fg/g serum), triglyceride concentration increased only about 0.4 mmol/l. No association was found between an abnormally elevated triglyceride (i.e., > 2.82 mmol/l) concentration and serum 2,3,7,8-tetrachlorodibenzo-p-dioxin concentration. An association was also found between serum 2,3,7,8-tetrachlorodibenzo-p-dioxin concentration and an abnormal high-density lipoprotein concentration (p = .09). In summary, there was evidence of an effect on lipid metabolism in a group of workers with high serum 2,3,7,8-tetrachlorodibenzo-p-dioxin concentrations. The influence of serum 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid concentrations, however, was small, compared with the influence of other factors.Keywords
This publication has 19 references indexed in Scilit:
- Blood lipid measurements. Variations and practical utilityPublished by American Medical Association (AMA) ,1992
- Rabbit serum Hypertriglyceridemia after administration of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD)Journal of Toxicology and Environmental Health, 1988
- Subchronic oral toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the guinea pig: Comparisons with a PCB-containing transformer fluid pyrolysateFundamental and Applied Toxicology, 1986
- Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five yearsAmerican Heart Journal, 1984
- Human health effects of 2,4,5-T and its toxic contaminantsJAMA, 1984
- Health status of workers with past exposure to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin in the manufacture of 2,4,5‐trichlorophenoxyacetic acid: Comparison of findings with and without chloracneAmerican Journal of Industrial Medicine, 1984
- Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Golden Syrian hamsterToxicology and Applied Pharmacology, 1980
- Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated ratsBiochemical Pharmacology, 1980
- Hematologic and Clinical Chemistry Effects of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Laboratory AnimalsEnvironmental Health Perspectives, 1973
- Enzymatic functions as targets of the toxicity of ?dioxin? (2,3,7,8-tetrachlorodibenzo-p-dioxin)The Science of Nature, 1972